Our internationally recognised publications give you access to the expertise of hundreds of the world’s leading scientists, experts and researchers.

Our unrivalled collection of publications spans evidence-based clinical knowledge, research and regulatory information. The extensive breadth of content on MedicinesComplete supports your decision making, from research to the point of care and provides you with the world’s most trusted resources.

We’re excited to announce the launch of two new resources: Martindale’s ADR Checker, a quick and easy tool to support you when managing patients with adverse drug reactions, and the Palliative Care Formulary, the expert source of drug information in palliative and hospice care.

Subscribe Publication Updates

Publication Updates

09 Jun
British National Formulary logo
BNF June 2020 Update

This update contains 7 significant changes, 2 dose changes and 8 new preparations.

Significant Changes:

  • Adrenaline/epinephrine auto-injectors (Emerade®): all strengths of auto-injector pens have been recalled from patients due to failure to activate. Healthcare professionals are advised to ensure that patients who have previously been prescribed an Emerade® 150, 300 or 500 microgram pen are supplied with a prescription for an alternative brand—see the MHRA website for full details [MHRA/CHM advice].
  • Hypoglycaemia: updated guidance on management.
  • Lenalidomide with rituximab for previously treated follicular lymphoma [NICE guidance].
  • Nurse Prescribers’ Formulary: list of medicinal preparations updated with indications for use by Community Practitioner Nurse Prescribers and links to BNF monographs. For further information, see How to use the NPF in the Nurse Prescribers’ Formulary (NPF).
  • Poisoning, emergency treatment: updated guidance on the management of beta-blockers poisoning in-line with TOXBASE recommendations.
  • Poisoning, emergency treatment: updated guidance on the management of paracetamol poisoning in-line with TOXBASE recommendations.
  • Skin infections, antibacterial therapy: updated guidance on management of impetigo.

Dose Changes:

  • Co-fluampicil [update to dosing information].
  • Fostair® NEXThaler 100/6 (beclometasone with formoterol) [dosing for maintenance and reliever therapy added].

New Preparations:

  • Ampres® [chloroprocaine hydrochloride].
  • Beovu® [brolucizumab].
  • Combisal® 25/50 [fluticasone with salmeterol].
  • Combisal® 25/125 [fluticasone with salmeterol].
  • Combisal® 25/250 [fluticasone with salmeterol].
  • Fusacomb 50/250 Easyhaler® [fluticasone with salmeterol].
  • Fusacomb 50/500 Easyhaler® [fluticasone with salmeterol].
  • Staladex® [leuprorelin acetate].

For further details on changes in the BNF click on http://www.medicinescomplete.com/mc/bnf/current/PHP107699-changes.htm 

09 Jun
Palliative Care Formulary June 2020 Update

This update contains 1 new monograph, 22 revised monographs and 6 discontinued monographs. Editorial Staff was a new monograph for this update.

The following monographs have been fully revised:

Abbreviations; Anaphylaxis; Barrier products; Demeclocycline; Drug-induced movement disorders; Drugs for pruritus; Emollients; *Ketamine; Nebulized drugs; Obtaining specials; *Octreotide; Potassium; Prescribing in children; Prescribing in palliative care; Systemic corticosteroids; Taking controlled and prescription drugs to other countries; Topical antipruritics; Urinary tract infections; Variability in response to drugs.

The following monographs have undergone minor revision:

Getting the most out of PCF; How PCF is constructed; Prolongation of the QT interval in palliative care.

The following monographs have been discontinued:

Cardiovascular system (introductory paragraph); Clostridium difficile infection; Flurbiprofen; Nabumetone; Orphenadrine; Prochlorperazine.

09 Jun
Clarke's Analysis of Drugs and Poisons logo
Clarke’s Analysis of Drugs and Poisons June 2020 Update

This update contains 9 new monographs and 6 major revisions to monographs, and full revisions to two chapters.

This update contains: 

  • Chapter 36: Nuclear Magnetic Resonance Spectroscopy has been fully revised
  • Chapter 38: Liquid Chromatography–Mass Spectrometry has been fully revised
  • 9 new full NPS monographs
  • 6 fully revised NPS monographs
  • 55 new spectra
  • Updated prelims
  • Updated indices
09 Jun
Stockley's Interactions Checker_logo
Stockley’s Interactions Checker June 2020 Update

New and updated interactions now available.

For June, 415 interactions have been added, and 10 existing interactions have been updated.

09 Jun
Martindale logo
Martindale: The Complete Drug Reference June 2020 Update

This update contains 1 new monograph and 2 existing monographs have been updated. Preparations have been updated for 7 countries.  

New monographs: 

  • Remdesivir is a nucleotide RNA polymerase inhibitor with antiviral activity that is being tried in the treatment of severe COVID-19 (coronavirus disease 2019) infection.

Notable revisions: 

  • Chloroquine is being tried in the treatment of COVID-19 (coronavirus disease 2019) infection.
  • Hydroxychloroquine is being tried in the treatment of COVID-19 (coronavirus disease 2019) infection.

Proprietary Preparations and Manufacturers updated for the following countries and regions: 

  • Chile
  • France
  • Monaco
  • India
  • Ukraine
  • USA
  • UK

† Countries updated on an ongoing basis 

 

09 Jun
British National Formulary for Children logo
BNF for Children June 2020 Update

This update contains 5 significant changes, 4 dose changes and 5 new preparations.

Significant Changes:

  • Adrenaline/epinephrine auto-injectors (Emerade®): all strengths of auto-injector pens have been recalled from patients due to failure to activate. Healthcare professionals are advised to ensure that patients who have previously been prescribed an Emerade® 150, 300 or 500 microgram pen are supplied with a prescription for an alternative brand—see the MHRA website for full details [MHRA/CHM advice].
  • Hypoglycaemia: updated guidance on management.
  • Poisoning, emergency treatment: updated guidance on the management of beta-blockers poisoning in-line with TOXBASE recommendations.
  • Poisoning, emergency treatment: updated guidance on the management of paracetamol poisoning in-line with TOXBASE recommendations.
  • Skin infections, antibacterial therapy: updated guidance on management of impetigo.

Dose Changes:

  • Co-fluampicil [update to dosing information].
  • Qvar® (beclometasone dipropionate) [age-range extension].
  • Seretide 50 Evohaler® (fluticasone with salmeterol) [age-range extension].
  • Seretide 100 Accuhaler® (fluticasone with salmeterol) [age-range extension].

New Preparations:

  • Combisal® 25/50 [fluticasone with salmeterol].
  • Combisal® 25/125 [fluticasone with salmeterol].
  • Combisal® 25/250 [fluticasone with salmeterol].
  • Fusacomb 50/250 Easyhaler® [fluticasone with salmeterol].
  • Fusacomb 50/500 Easyhaler® [fluticasone with salmeterol].

 

For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes 

View more